ICU Medical ICUI Restructuring, strategic transaction and integration expenses
Restructuring, strategic transaction and integration expenses at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept icui:Restructuringandstrategictransactionexpense.
The official record: ICU Medical’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about ICU Medical's restructuring, strategic transaction and integration expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ICU Medical's restructuring, strategic transaction and integration expenses?
- ICU Medical (ICUI) reported restructuring, strategic transaction and integration expenses of $16.63M in Q4 2025.
- How has ICU Medical's restructuring, strategic transaction and integration expenses changed year-over-year?
- ICU Medical's restructuring, strategic transaction and integration expenses increased by 11.1% year-over-year, from $14.96M to $16.63M.
- What is the long-term trend for ICU Medical's restructuring, strategic transaction and integration expenses?
- Over 4 years (2021 to 2025), ICU Medical's restructuring, strategic transaction and integration expenses has grown at a 38.6% compound annual growth rate (CAGR), from $18.04M to $66.51M.
- What does restructuring, strategic transaction and integration expenses mean?
- This metric represents costs incurred from organizational restructuring, business integrations, and strategic transaction activities, such as acquisition-related expenses. It highlights the financial impact of transforming the business model or absorbing newly acquired entities. Investors monitor this to distinguish between ongoing operational costs and non-recurring expenses related to corporate strategy.